In particular, 4T1.2/HER2 tumor-bearing mice showed approximately 80% HER263–71-specific CTL lytic activity, whereas CT26/HER2 tumor-bearing mice displayed no HER263–71-specific CTL lytic activity (Figure 4C). Here, ERBB2 is linked to neoplasm.